Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

NCT01535222 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Bypass Graft
Cardiopulmonary Bypass

Interventions

DRUG: MDCO-2010
DRUG: Placebo

Sponsor

The Medicines Company